A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease - Pacifico, L; Bonci, E; Di Martino, M (Nutr Metab Cardiovasc Dis, 2015)
et al.